NASDAQ: SBC
Sbc Medical Group Holdings Inc Stock Forecast, Predictions & Price Target

Analyst price target for SBC

Based on 1 analyst offering 12 month price targets for Sbc Medical Group Holdings Inc

Min Forecast
$8.00+124.72%
Avg Forecast
$8.00+124.72%
Max Forecast
$8.00+124.72%

Should I buy or sell SBC stock?

Based on 1 analyst offering ratings for Sbc Medical Group Holdings Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SBC stock forecasts and price targets.

SBC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-03-06

1 of 1

Forecast return on equity

Is SBC forecast to generate an efficient return?

Company
24.65%
Industry
153.73%
Market
150.38%
SBC's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SBC forecast to generate an efficient return on assets?

Company
19.02%
Industry
13.34%
SBC is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SBC earnings per share forecast

What is SBC's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
$0.50+21.95%
Avg 2 year Forecast
$0.60+45.34%
SBC's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

SBC revenue forecast

What is SBC's revenue in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
$193.3M+8.31%
Avg 2 year Forecast
$216.0M+21.05%
SBC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SBC earnings growth forecast

How is SBC forecast to perform vs Consulting Services companies and vs the US market?

Company
21.95%
Industry
41.45%
Market
1,669.49%
SBC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
SBC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
SBC's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

SBC revenue growth forecast

How is SBC forecast to perform vs Consulting Services companies and vs the US market?

Company
8.31%
Industry
8.14%
Market
26.25%
SBC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SBC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SBC vs Consulting Service Stocks

TickerPricePrice TargetUp/downsideConsensus
SBC$3.56$8.00+124.72%Strong Buy
ROMA$5.40N/AN/A
EFTY$15.02N/AN/A
EGG$6.00N/AN/A
LAWR$3.75N/AN/A

Sbc Medical Group Holdings Stock Forecast FAQ

Is Sbc Medical Group Holdings Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: SBC) stock is to Strong Buy SBC stock.

Out of 1 analyst, 1 (100%) are recommending SBC as a Strong Buy, 0 (0%) are recommending SBC as a Buy, 0 (0%) are recommending SBC as a Hold, 0 (0%) are recommending SBC as a Sell, and 0 (0%) are recommending SBC as a Strong Sell.

If you're new to stock investing, here's how to buy Sbc Medical Group Holdings stock.

What is SBC's earnings growth forecast for 2026-2027?

(NASDAQ: SBC) Sbc Medical Group Holdings's forecast annual earnings growth rate of 21.95% is not forecast to beat the US Consulting Services industry's average forecast earnings growth rate of 41.45%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 1,669.49%.

Sbc Medical Group Holdings's earnings in 2026 is $43,324,543.On average, 4 Wall Street analysts forecast SBC's earnings for 2026 to be $51,288,472, with the lowest SBC earnings forecast at $49,257,448, and the highest SBC earnings forecast at $53,852,895.

In 2027, SBC is forecast to generate $61,125,600 in earnings, with the lowest earnings forecast at $59,309,988 and the highest earnings forecast at $63,546,416.

What is SBC's revenue growth forecast for 2026-2027?

(NASDAQ: SBC) Sbc Medical Group Holdings's forecast annual revenue growth rate of 8.31% is forecast to beat the US Consulting Services industry's average forecast revenue growth rate of 8.14%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 26.25%.

Sbc Medical Group Holdings's revenue in 2026 is $178,461,320.On average, 4 Wall Street analysts forecast SBC's revenue for 2026 to be $19,827,097,312, with the lowest SBC revenue forecast at $19,070,079,473, and the highest SBC revenue forecast at $20,929,799,450.

In 2027, SBC is forecast to generate $22,158,671,227 in revenue, with the lowest revenue forecast at $21,023,144,468 and the highest revenue forecast at $23,547,563,035.

What is SBC's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: SBC) forecast ROA is 19.02%, which is higher than the forecast US Consulting Services industry average of 13.34%.

What is SBC's Price Target?

According to 1 Wall Street analyst that have issued a 1 year SBC price target, the average SBC price target is $8.00, with the highest SBC stock price forecast at $8.00 and the lowest SBC stock price forecast at $8.00.

The Wall Street analyst predicted that Sbc Medical Group Holdings's share price could reach $8.00 by Mar 6, 2027. The average Sbc Medical Group Holdings stock price prediction forecasts a potential upside of 124.72% from the current SBC share price of $3.56.

What is SBC's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: SBC) Sbc Medical Group Holdings's current Earnings Per Share (EPS) is $0.41. On average, analysts forecast that SBC's EPS will be $0.50 for 2026, with the lowest EPS forecast at $0.48, and the highest EPS forecast at $0.53. In 2027, SBC's EPS is forecast to hit $0.60 (min: $0.58, max: $0.62).

What is SBC's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: SBC) forecast ROE is 24.65%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.